# Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

> **NCT03433131** · — · NO_LONGER_AVAILABLE · sponsor: **Harmony Biosciences Management, Inc.**

## Conditions studied

- Narcolepsy Without Cataplexy
- Narcolepsy With Cataplexy

## Interventions

- **DRUG:** Pitolisant

## Key facts

- **NCT ID:** NCT03433131
- **Lead sponsor:** Harmony Biosciences Management, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433131, "Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03433131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*